Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury
University of California, Irvine · Institute of Neurobiology
Abstract
Demyelination contributes to loss of function after spinal cord injury, and thus a potential therapeutic strategy involves replacing myelin-forming cells. Here, we show that transplantation of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells (OPCs) into adult rat spinal cord injuries enhances remyelination and promotes improvement of motor function. OPCs were injected 7 d or 10 months after injury. In both cases, transplanted cells survived, redistributed over short distances, and differentiated into oligodendrocytes. Animals that received OPCs 7 d after injury exhibited enhanced remyelination and substantially improved locomotor ability. In contrast, when OPCs were transplanted 10…
Citation impact
- FWCI
- 23.47
- Percentile
- 100%
- References
- 51
Authors
7- HSHans S. KeirsteadCorresponding
University of California, Irvine
- GNGabriel Nistor
University of California, Irvine, Institute of Neurobiology
- GMGiovanna M. Bernal
University of California, Irvine, Institute of Neurobiology
- MOMinodora O. Totoiu
University of California, Irvine, Institute of Neurobiology
- FCFrank Cloutier
University of California, Irvine, Institute of Neurobiology
Topics & keywords
- Remyelination
- Spinal cord injury
- Embryonic stem cell
- Stem cell
- Oligodendrocyte
- Transplantation
- Spinal cord
- Progenitor cell
- Good health and well-being